NYRADA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.092 AUD | -2.13% |
|
-6.12% | +318.18% |
| Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
| Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
Valuation
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 19.14 | 49.92 | 21.06 | 4.368 |
| Enterprise Value (EV) 1 | 14.34 | 36.17 | 10.25 | 0.6595 |
| P/E ratio | -1.85 x | -10.6 x | -4.5 x | -0.56 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 17,008,986 x | 21,370,854 x | 19,256,036 x | 3,054,918 x |
| EV / Revenue | 12,740,471 x | 15,484,461 x | 9,367,032 x | 461,207 x |
| EV / EBITDA | -2.55 x | -10.2 x | -2.58 x | -0.08 x |
| EV / FCF | -5,940,428 x | -32,266,676 x | -6,817,981 x | -154,775 x |
| FCF Yield | -0% | -0% | -0% | -0% |
| Price to Book | 3.46 x | 3.44 x | 1.83 x | 1.03 x |
| Nbr of stocks (in thousands) | 109,384 | 156,009 | 156,009 | 156,009 |
| Reference price 2 | 0.1750 | 0.3200 | 0.1350 | 0.0280 |
| Announcement Date | 9/7/20 | 8/30/21 | 8/29/22 | 8/28/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | 0.4863 | 1.125 | 2.336 | 1.094 | 1.43 |
| EBITDA 1 | -2.182 | -3.462 | -5.632 | -3.536 | -3.967 | -7.924 |
| EBIT 1 | -2.182 | -3.464 | -5.633 | -3.538 | -3.972 | -7.931 |
| Operating Margin | - | -712.18% | -500.55% | -151.44% | -363.17% | -554.62% |
| Earnings before Tax (EBT) 1 | -2.416 | -4.095 | -5.774 | -3.539 | -3.96 | -7.782 |
| Net income 1 | -2.416 | -4.095 | -5.774 | -3.539 | -3.96 | -7.782 |
| Net margin | - | -842.03% | -513.03% | -151.51% | -362.03% | -544.21% |
| EPS | - | -0.4095 | -0.0948 | -0.0303 | -0.0300 | -0.0500 |
| Free Cash Flow | - | -1.133 | -2.414 | -1.121 | -1.503 | -4.261 |
| FCF margin | - | -232.99% | -214.47% | -47.99% | -137.39% | -297.99% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 1/14/20 | 1/14/20 | 9/7/20 | 8/30/21 | 8/29/22 | 8/28/23 |
1AUD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.17 | 2.83 | - | - | - | - |
| Net Cash position 1 | - | - | 4.8 | 13.8 | 10.8 | 3.71 |
| Leverage (Debt/EBITDA) | -0.0785 x | -0.8168 x | - | - | - | - |
| Free Cash Flow | - | -1.13 | -2.41 | -1.12 | -1.5 | -4.26 |
| ROE (net income / shareholders' equity) | - | 130% | -2,018% | -35.4% | -30.5% | -98.8% |
| ROA (Net income/ Total Assets) | - | -100% | -95% | -20.6% | -18.3% | -57.7% |
| Assets 1 | - | 4.08 | 6.076 | 17.15 | 21.67 | 13.49 |
| Book Value Per Share | - | -0.5000 | 0.0500 | 0.0900 | 0.0700 | 0.0300 |
| Cash Flow per Share | - | 0.1100 | 0.0500 | 0.0900 | 0.0700 | 0.0200 |
| Capex 1 | 0 | 0 | 0 | 0.01 | 0 | - |
| Capex / Sales | - | 0.09% | 0.27% | 0.21% | 0.43% | - |
| Announcement Date | 1/14/20 | 1/14/20 | 9/7/20 | 8/30/21 | 8/29/22 | 8/28/23 |
1AUD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +318.18% | 10.95M | |
| +34.00% | 704B | |
| +27.16% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +14.70% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
- Stock Market
- Equities
- NYR Stock
- Financials Nyrada Inc.
